filmov
tv
2019 FNIH Biomarkers Consortium Neuroscience Symposium Session 3 - Imaging Biomarkers
![preview_player](https://i.ytimg.com/vi/NjWRkJZ5wjQ/maxresdefault.jpg)
Показать описание
0:00:45 - Session Introduction - Anthony Fotenos, FDA
0:10:38 - Session Introduction - Hartmuth Kolb, Janssen
0:12:30 - PET Tracers of CNS Neurotransmitter Drug Targets: Applications To Date - Jeff Meyer, University of Toronto
0:31:20 - Emerging PET Radiotracers and Targets for Imaging of Neuroinflammation - Neil Vasdev, University of Toronto
1:02:00 - Cortical Thinning and Cerebello-Thalamo-Cortical Hyperconnectivity in the Psychosis Syndrome - Tyronne Cannon, Yale University
1:25:40 - Developing Therapeutically Relevant and Neurobiologically Grounded Human Neuroimaging Markers for Psychosis - Alan Anticevic, Yale University
1:45:30 - DAT Imaging as an enrichment biomarker for PD Clinical Trials - Diane Stephenson, Critical Path Institute
2:26:21 - Imaging Biomarker Qualification Panel Discussion
0:10:38 - Session Introduction - Hartmuth Kolb, Janssen
0:12:30 - PET Tracers of CNS Neurotransmitter Drug Targets: Applications To Date - Jeff Meyer, University of Toronto
0:31:20 - Emerging PET Radiotracers and Targets for Imaging of Neuroinflammation - Neil Vasdev, University of Toronto
1:02:00 - Cortical Thinning and Cerebello-Thalamo-Cortical Hyperconnectivity in the Psychosis Syndrome - Tyronne Cannon, Yale University
1:25:40 - Developing Therapeutically Relevant and Neurobiologically Grounded Human Neuroimaging Markers for Psychosis - Alan Anticevic, Yale University
1:45:30 - DAT Imaging as an enrichment biomarker for PD Clinical Trials - Diane Stephenson, Critical Path Institute
2:26:21 - Imaging Biomarker Qualification Panel Discussion